Glimepiride
NDC 16571-774, Glimepiride, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-774
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202759
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-774 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIMEPIRIDE2 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-774-01 | 16571077401 | 100 TABLET in 1 BOTTLE (16571-774-01) |
| 16571-774-50 | 16571077450 | 500 TABLET in 1 BOTTLE (16571-774-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/48ada723-8144-497d-afd6-a8c52a1dd3ffNADAC price for package 16571077401
GET /v1/drugs/nadac/16571077401NADAC price for package 16571077450
GET /v1/drugs/nadac/16571077450
Use it
Look up 16571-774 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-774 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-774. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.